Macrophage-like THP-1 cells show effective uptake of silica nanoparticles carrying inactivated diphtheria toxoid for vaccination

Macrophage-like THP-1 cells show effective uptake of silica nanoparticles carrying inactivated diphtheria toxoid for vaccination

Bibliographic Details
Main Authors:	Huang, X, Cavalcante, D, Townley, H
Format:	Journal article
Language:	English
Published:	Springer 2020

Similar Items

ADJUVANT PROPERTIES OF NANOPARTICLES IMMOBILIZED RECOMBINANT DIPHTHERIA TOXOID FRAGMENT
by: T. O. Chudina, et al.
Published: (2017-08-01)

Investigating preparation and characterisation of diphtheria toxoid‐loaded on sodium alginate nanoparticles
by: Samira Aghamiri, et al.
Published: (2022-07-01)

INTERACTION OF RECOMBINANT DIPHTHERIA TOXOIDS WITH CELLULAR RECEPTORS in vitro
by: K. Yu. Manoilov, et al.
Published: (2016-06-01)

Current state of methods for control the safety and potency of diphtheria toxoid and tetanus toxoid in combined vaccines
by: E. I. Komarovskaya, et al.
Published: (2022-07-01)

Evaluation of the immune response to diphtheria and tetanus toxoids by the serological methods
by: Е. I. Komarovskaya, et al.
Published: (2023-10-01)

Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population
by: Ahmad Faudzi Yusoff, et al.
Published: (2021-06-01)

COMPLEXATION OF CURCUMIN WITH BOVINE SERUM ALBUMIN AND DIPHTHERIA TOXOID CRM197
by: Zhukova D.A., et al.
Published: (2023-12-01)

Mass psychogenic illness following tetanus-diphtheria toxoid vaccination in Jordan
by: Kharabsheh Saad, et al.
Published: (2001-01-01)

Adverse Effects of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine in 6- to 7-Year-Old Children
by: Sung-Hsi Wei, et al.
Published: (2011-02-01)

Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
by: Ammar Hussam
Published: (2011-10-01)

Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India
by: Hitt J Sharma, et al.
Published: (2023-12-01)

Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants
by: Hye-Kyung Cho, et al.
Published: (2021-12-01)

Molecular Responses in THP-1 Macrophage-Like Cells Exposed to Diverse Nanoparticles
by: Tana Brzicova, et al.
Published: (2019-05-01)

Evaluation of Immunogenicity of Yersinia enterocolitica O:8 Oligopolysaccaride-DiphtheriaeToxoide Conjugate in Mice
by: SM Rezavian, et al.
Published: (2015-06-01)

Production of recombinant SARS-COV-2 proteins and diphtheria toxoid CRM197-based fusion
by: O. I. Krynina, et al.
Published: (2021-12-01)

Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
by: Vivek Kumar, et al.
Published: (2018-01-01)

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
Published: (2020-03-01)

M2 polarization enhances silica nanoparticle uptake by macrophages
by: Jessica eHoppstädter, et al.
Published: (2015-03-01)

Epitope Profiling of Diphtheria Toxoid Provides Enhanced Monitoring for Consistency Testing during Manufacturing Process Changes
by: Camille Houy, et al.
Published: (2022-05-01)

SYNTHESIS AND CHARACTERIZATION OF POLY(D,L-LACTIC-CO-GLYCOLIC)ACID MICROPARTICLES LOADED BY DIPHTHERIA TOXOID
by: T. O. Chudina, et al.
Published: (2018-04-01)

Quantificação de anticorpos diftéricos em cobaias: I - persistência do título de anticorpos séricos em animais inoculados com uma dose de toxóide diftérico Quantitative determination of diphtheria antibodies in guinea pigs: I - persistency of diphtheria antitoxin levels in sera of animals inoculated with diphtheria toxoid
by: Joana Akiko Furuta, et al.
Published: (1982-04-01)

The seroprevalence, waning rate, and protective duration of anti-diphtheria toxoid IgG antibody in Nha Trang, Vietnam
by: Noriko Kitamura, et al.
Published: (2022-03-01)

An assessment of mesoporous silica nanoparticle architectures as antigen carriers
by: Huang, X, et al.
Published: (2020)

Diphtheria anti-toxoid antibody levels among pre-clinical students and staff in an institute of higher learning in Malaysia: are they protected?
by: Awang Hamat, Rukman, et al.
Published: (2011)

Evaluation of Potency on Diphtheria and Tetanus Toxoid for Adult Vaccines by In Vivo Toxin Neutralization Assay Using National Reference Standards
by: Chan Woong Choi, et al.
Published: (2018-10-01)

Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein – conjugated pneumococcal vaccine in Filipino infants
by: Käyhty Helena, et al.
Published: (2003-08-01)

Short-term and long-term antibody response by mice after immunization against Neisseria meningitidis B or diphtheria toxoid
by: G.P. Silva, et al.
Published: (2013-02-01)

Spontaneously Occurring Small-Colony Variants of Staphylococcus aureus Show Enhanced Clearance by THP-1 Macrophages
by: Simon M. Stoneham, et al.
Published: (2020-06-01)

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.
by: Keyserling, H, et al.
Published: (2006)

Arsenic exposure and serum antibody concentrations to diphtheria and tetanus toxoid in children at age 5: A prospective birth cohort in Bangladesh
by: Barrett M. Welch, et al.
Published: (2019-06-01)

Transcriptome Analysis of Co-Cultures of THP-1 Human Macrophages with Inactivated Germinated <i>Trichophyton rubrum</i> Conidia
by: Bruna Aline Cantelli, et al.
Published: (2023-05-01)

Instruction for Medical Use Drug MENAKTRA (Vaccine Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Conjugated to Diphtheria Toxoid)
by: Editorial Article
Published: (2016-04-01)

Pseudomonas aeruginosa PAO1 outer membrane vesicles-diphtheria toxoid conjugate as a vaccine candidate in a murine burn model
by: Ehsan Zare Banadkoki, et al.
Published: (2022-12-01)

PMA-Induced THP-1 Macrophage Differentiation is Not Impaired by Citrate-Coated Platinum Nanoparticles
by: Francesca Gatto, et al.
Published: (2017-10-01)

Impact of Superparamagnetic Iron Oxide Nanoparticles on THP-1 Monocytes and Monocyte-Derived Macrophages
by: Christina Polasky, et al.
Published: (2022-02-01)

Awareness and Uptake of Tetanus Toxoid Vaccination Among Females of Reproductive Age in Rawalpindi
by: Shumaila Humayun, et al.
Published: (2023-04-01)

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal
by: Shipra Chaudhary, et al.
Published: (2023-01-01)

Increased Uptake of Silica Nanoparticles in Inflamed Macrophages but Not upon Co-Exposure to Micron-Sized Particles
by: Eva Susnik, et al.
Published: (2020-09-01)

Efficacy of Freeze Dried Inactivated Equine Influenza, Equine Herpesvirus-1 and Tetanus Toxoid Vaccine
by: Nashwa K. Madkour, et al.
Published: (2023-06-01)

Comparative protection of small ruminants against Mannheimia haemolytica infection by inactivated bacterin and toxoid vaccines
by: Dounia Bkiri, et al.
Published: (2023-01-01)